Publications by authors named "Brian Hammann"

Claim this Profile
D
Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.
Carmen Segrelles, Jerry Lu, Brian Hammann, Mirentxu Santos, Marta Moral

Cancer Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer.
Celia A Kanashiro, Andrew V Schally, Marta Zarandi, Brian D Hammann, Jozsef L Varga

Int J Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, Marta Zarandi, Ren-Zhi Cai, Brian D Hammann

Eur J Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, Brian D Hammann, Kate Groot

Prostate· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma.
Celia A Kanashiro, Andrew V Schally, Jozsef L Varga, Brian Hammann, Gabor Halmos

Cancer Lett· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.
Gunhild Keller, Jörg B Engel, Andrew V Schally, Attila Nagy, Brian Hammann

Int J Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Jörg B Engel, Gunhild Keller, Andrew V Schally, Gabor Halmos, Brian Hammann

Clin Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of growth of H-69 small cell lung carcinoma by antagonists of growth hormone releasing hormone and bombesin is associated with an inhibition of protein kinase C signaling.
Celia A Kanashiro, Andrew V Schally, Marta Zarandi, Brian D Hammann, Jozsef L Varga

Int J Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis